drugset / Trial / NCT04950933
The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules
Phase 2/3
Unknown
144 enrolled
Peking University Third Hospital
The Second Hospital of Hebei Medical University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study intends to evaluate the efficacy and safety of Dong Lingsheng Ji Granule in the treatment of amyotrophic lateral sclerosis (spleen deficiency, kidney-yang deficiency syndrome) in comparison with riluzole, so as to provide data support for marketing application or subsequent clinical research design.
Timeline
- Start
- 2020-06-01
- Primary completion
- 2021-12-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huolingshengji Granules | Unknown | 1 unknown | Oral |
| Comparator | Riluzole | Small molecule | 1 unknown | Oral |